Celiac Disease Treatment Market Research Report: By Treatment, By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2030

Market Overview

The Celiac Disease Treatment Market is anticipated to have a significant growth with a 11.03% CAGR. Therefore, the market value will further increase up to USD 1,061.20 Million in the studied forecast period 2020-2030. Celiac disease is basically an auto-immune and genetic disorder. This disease damages the small intestine and causes various diseases such as neurological disorders, low bone density, infertility, and even cancers.

Several factors such as the penetration of therapeutic products among developing countries are empowering the Celiac Disease Treatment Market Growth. However, the growing awareness for healthcare and technological advancements will improve the market growth in this region. It is anticipated that the Asia-Pacific region will rise to significant CAGR during the studied forecast period.

COVID-19 Analysis

Governments across the world were highly affected due to the outbreak of the COVID-19 disease. It put a huge burden on the healthcare sector to treat the affected patients. Due to this reason, treatment of other diseases was highly affected. However, the development of vaccines and waiver of lockdown has helped the market to improve its growth. Along with that, the market players are investing to improve Celiac Disease Treatment Market Growth in the future years.

Market Dynamics

Market Drivers

Various drivers such as the rising use of therapeutic drugs, diseases like diabetes, and favorable policies by governments will boost the market. Additionally, the prevalence of junk and packaged foods, rising disposable income will further drive the Celiac Disease Treatment Market in the future years.

Restraints

The low availability of specialized treatment across various underdeveloped and developing countries can restraint the market growth. Also, low awareness and lack of skilled professionals for diagnosis can hamper the market growth significantly.

Opportunities

Various opportunities such as investments by the key players can offer new opportunities for the market. Acquisitions, collaborations, mergers, partnerships, etc. are anticipated to open new opportunities for the Celiac Disease Treatment Market.

Challenges

As of now, there is still no drug available for the treatment of celiac disease. Along with that, the misdiagnosis of the treatment can be a major challenge for the Celiac Disease Treatment Market Growth.

Cumulative Analysis

The Compound Annual Growth Rate (CAGR) of the Celiac Disease Treatment Market is estimated to touch 12%. Therefore, the market value will further increase up to USD 680.5 Million in the studied forecast period 2021-2028. The rising technological developments and improvement in the treatment of the disease will have a significant impact on the market.

Value Chain Analysis

The Celiac Disease Treatment Market Analysis suggests that the market will grow significantly in the upcoming years. The rising developments and several drivers such as increasing cases of diabetes and other neurological diseases will further increase the Celiac Disease Treatment Market Trends. Therefore, the value chain will improve in the forthcoming years.

Market Segmentations

The Celiac Disease Treatment Market Size is divided into various segments such as treatment, drugs, enzyme type, and end-user. On the basis of treatment, the market is fragmented into Immunosuppressive Drugs and Steroids, Therapeutic Vaccines, and Dietary and Vitamin Supplements.

On the basis of drugs, the Celiac Disease Treatment Market is segmented into Second-Line Treatment and First-Line Treatment.

On the basis of enzyme type, the Market is bifurcated into Gas, Bloating, Fatigue, Diarrhoea, Distension, and Others.

On the basis of end-user, the Market is segmented into Clinical Research Organisations, Clinics, and Hospitals, and Academic Institutes.

Regional Analysis

Regionally, the Celiac Disease Treatment Market Size is divided into Europe, Americas, Africa, and the Middle East, and Asia-Pacific. The Americas is expected to hold the largest share in the upcoming years. The rising cases of celiac diseases are one of the celiac diseases and the presence of various key players among the countries is pushing the market growth.

Secondly, Europe will have the second-largest Celiac Disease Treatment Market Share in the upcoming years. The increasing expenditure in the healthcare and presence of advanced healthcare infrastructure is evaluated to improve the market growth in the upcoming years.

Asia-Pacific region is anticipated to record the fastest growth in the future years. Mainly countries such as India, China are developing at a rapid speed. As a result, the market will have significant growth in the future years.

Africa and the Middle East region are evaluated to have the least share in the Celiac Disease Treatment Market. Hence, various underdeveloped nations and low infrastructure are the major cause of the slow growth rate.

Competitive Landscape

The Celiac Disease Treatment Market is fragmented with the presence of various key players. These key players play a crucial role in elevating market growth. They do strategic developments such as acquisitions, partnerships, collaborations, new ventures, etc. Some of the key players in the market are as follows.

• General Mills Inc. (US)


• Hain Celestial Group Inc. (US)


• Amgen Inc. (US)


• Glenmark Pharmaceuticals Inc. (India)


• Amneal Pharmaceuticals LLC (US)


• Freedom Foods Group Limited (Australia)


• Kellogg Company (US)


• The Kraft Heinz Company (US)


• Pinnacle Foods, Inc. (US)


• Takeda Pharmaceuticals Company Ltd. (Japan)


• Mondelez International Inc., (US)


• West-Ward Pharmaceutical (US)


• Calypso Biotech SA (Switzerland)


• BioLineRx (Israel)


• Zedira GmbH (Germany)


• Innovative Biopharmaceuticals Inc. (US)


• Mylan Pharmaceuticals Inc. (US)


• Zydus Pharmaceuticals Inc. (US)

Recent Developments

No recent developments were found.

Report Overview

The overview of the Celiac Disease Treatment Market Outlook is listed below.

• Market Overview


• COVID-19 Analysis


• Dynamics of the Market


• Value Chain Analysis


• Market Segmentation


• Regional Analysis


• Competitive Analysis


• Recent Development

Report Score and Segmentation

The report score of the Celiac Disease Treatment Market Forecast is to highlight information such as market CAGR value, opportunities, drivers, key players, recent development, etc. Furthermore, the information provided in this report is collected from various secondary and primary sources.

• 
  Study Period- 2021-2028


• 
  Base Year-2021


• 
  Forecast Period- 2021-2028


• 
  Historical Period-2017-2020

Segmentation

By Treatment

• Immunosuppressive Drugs and Steroids


• Therapeutic Vaccines


• Dietary and Vitamin Supplements

By Drug

• Second-Line Treatment


• First-Line Treatment

By Enzyme Type

• Gas


• Bloating


• Fatigue


• Diarrhea


• Distension


• Others

End-User

• Clinical Research Organisations


• Clinics and Hospitals


• Academic Institutes

By Region

• Americas


• Africa and the Middle East


• Asia-Pacific


• Europe